Ergomed is one of the market leaders in “co-development” partnerships signing its first partnership agreement in 2006. The scope of each relationship is tailored to the individual needs of the partner but can include clinical development management and services, development consultancy, fund raising or financial support for client companies.
Co-Development offers companies the ability to move more products into clinical development and to increase the speed and efficiency of their current development projects and adds diversity to portfolios. Ergomed benefits by becoming a long term partner on individual products and sharing in the longer term upside when products are successfully partnered and marketed.
The Co-Development approach can be seen as an alternative or a supplement to equity financing.